Sign in
CompletedNo phase

ACB With S-ESPB Versus ACB With iPACK for Knee Arthroplasty

Key facts

Who runs it
Poznan University of Medical Sciences
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
25 Dec 2025
Ended
4 Oct 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Adductor Canal Block
  • Sacral Erector Spinae Plane Block
  • iPACK Block
Record updated
19 October 2026

Who can take part

Age
65 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Age 65 years or older
  • Scheduled for elective unilateral total knee arthroplasty under spinal or general anesthesia
  • ASA physical status I-III
  • Planned use of regional anesthesia with an adductor canal block as part of multimodal analgesia
  • Ability to communicate pain intensity using the NRS scale
  • Written informed consent obtained from the patient

Who cannot take part

  • Chronic opioid therapy (>30 days of daily opioid use before surgery)
  • Previous knee arthroplasty on the same side or revision TKA (jeśli chcesz tylko primary TKA)
  • Allergy, intolerance, or contraindication to local anesthetics (ropivacaine)
  • Infection at or near the planned needle insertion sites
  • Severe hepatic or renal impairment
  • Cognitive impairment or delirium preventing reliable pain assessment BMI > 40 kg/m² (optional - if chcesz ograniczyć ze względu na trudność USG)
  • Coagulopathy or anticoagulation that contraindicates peripheral nerve blocks (e.g., INR >1.5, platelets <100,000/µL, or therapeutic anticoagulation that cannot be safely paused)
  • Refusal or inability to provide informed consent
  • Pre-existing significant neurological deficit or neuropathy in the operative limb
  • Pregnancy or breastfeeding
  • Participation in another interventional clinical trial within 30 days

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will compare two regional anesthesia strategies for pain management after total knee arthroplasty in adults. Both strategies use an adductor canal block (ACB) to provide analgesia while preserving quadriceps muscle strength. The ACB is then combined with either a sacral erector spinae plane block (S-ESPB) or an iPACK (infiltration between the popliteal artery and the posterior capsule of the knee) block to improve posterior knee analgesia.

Read full original descriptionShow less

All patients will receive an ultrasound-guided adductor canal block with 20 mL of 0.2% ropivacaine. They will then be randomly assigned to one of two groups:

Group 1: ACB combined with a sacral erector spinae plane block (S-ESPB) using 20 mL of 0.2% ropivacaine.

Group 2: ACB combined with an iPACK block using 20 mL of 0.2% ropivacaine. Both techniques aim to provide effective postoperative analgesia while minimizing motor blockade and allowing for early mobilization. It is not known whether combining ACB with S-ESPB or with iPACK provides superior pain control, reduces opioid requirements, or results in better functional recovery after total knee arthroplasty.

The main purpose of this study is to compare the time to first rescue analgesia and overall postoperative pain control between the two regional anesthesia strategies. The study will also evaluate opioid consumption, motor function, functional mobility, side effects, and block-related complications.

We hypothesize that both combinations will provide effective analgesia, but their impact on pain intensity, duration of analgesia, and functional recovery may differ.

The 2 groups in the trial

  • Adductor Canal Block Plus Sacral Erector Spinae Plane Block (ACB + S-ESPB)Existing treatment, for comparison

    Participants will receive an ultrasound-guided adductor canal block with 20 mL of 0.2% ropivacaine and a sacral erector spinae plane block with 20 mL of 0.2% ropivacaine. All patients will receive standard perioperative care and multimodal analgesia.

    Treatment: Adductor Canal Block and Sacral Erector Spinae Plane Block

  • Adductor Canal Block Plus iPACK Block (ACB + iPACK)Existing treatment, for comparison

    Participants will receive an ultrasound-guided adductor canal block with 20 mL of 0.2% ropivacaine and an iPACK block with 20 mL of 0.2% ropivacaine. All patients will receive standard perioperative care and multimodal analgesia.

    Treatment: Adductor Canal Block and iPACK Block

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison of Adductor Canal Block Combined With Sacral Erector Spinae Plane Block Versus Adductor Canal Block Combined With iPACK Block in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Tria
Record updated
19 October 2026